I. Introduction
The Candida species are one of the most common causes of blood stream infections (BSIs). 1, 2, 3 As per initial records, C. albicans has been considered as the frequent fungal isolate causing neonatal candidemia, but in the recent years there has been a mycological shift towards non-albicans Candida (NAC) species. 4, 5, 6, 7, 8 . Various factors such as broad spectrum antibiotics, low birth weight (LBW), prematurity, total parental nutrition, artificial ventilation, and /or history of fungal colonization contribute to the risk of candidal sepsis. 3, 8, 9 Candida can also spread through vertical transmission from maternal flora or via horizontal transmission from hands of healthcare workers (HCW), 10, 11 The important concern associated with isolation of NAC species is the increased resistance to antifungal drugs, thus contributing to morbidity and mortality. 
II. Materials And Method
The prospective study was carried out in the Post Graduate Department of Microbiology, Subharti Medical College and associated ChhatrapatiShivajiSubharti Hospital, Meerut, from May 2017 to April 2018. The study group included the neonates admitted in NICU with the clinical diagnosis of septicaemia. 
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III. Results
Out of total of 440neonates clinically suspected of septicemia, 312 (70.9%) cases were blood culture positive and the remaining 128( 29.1%) cases were blood culture negative. Out of culture positive cases, pure growth of Candida was isolated from 37. 5% (117/312), pure growth of bacteria from 53.8% (168/312) and mixed growth of bacteria and yeast from 8.6%(27/312) cases. Second blood sample was collected from 90 neonates out of 117,and both the sets of blood culture showed growth of Candida with same speciation,but in the remaining 27 neonates , even though the second sample could not be collected but these neonates were CRP positive. Thus,the frequency of neonatal candidemia in our set up was 37.5% (117/ 440).Out of the total of 117 cases of neonatal candidemia,NAC species were isolated in 96 (82.06%)cases and in the remaining 21 (Figure 8 ).In the present study,C. tropicalis (43.58%), was thepredominant isolate, followed by C.albicans (17.94%),C. parapsilosis(17.09%), C. glabrata (8.54%) and C. krusei (5.12%) [Table1] .Among the risk factors, prematurity (76.92%) was the commonest followed by LBW (64.10%), prolonged antibiotic usage (48.71%), steroid therapy(13.67%) and ventilator support (11.11%).[ Table  3 ].The most common clinical presentation was feed intolerance (76.06%),, followed by abdominal distension (64.95%), lethargy(60.68%)and failure to gain weight. (Table 3 ). 
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IV. Discussion
Reporting of fungal blood stream infection and spectrum of species involved are essential measures in any intensive care unit in order to implement appropriate preventive and therapeutic strategies. The incidence of candidemia in neonates has increased substantially, due to multiple risk factors.
In our tertiary care hospital, the frequency of neonatal candidemia was 37.5%. In 2018, Shettigar CGetal.
l3 reported the frequency of candidal sepsis in 9.59% of neonates in Mangalore. Rani et al. 14 found candidemia in 34.7% of neonates in New Delhi, which is comparable to our study. A study by Roy et al. 15 found 16 reported isolation of Candida species from blood in 13.6%cases of neonatal septicemia from Lucknow. In the present study, NAC species accounted for 82.06% of the cases of neonatal candidemia, whereas C.albicanswas responsible for 17.94% of cases. In 2018, Fu J et al. 17 found that 56.5% cases of neonatal candidemia were caused by NAC species in Western China. The predominance of NAC species in candidal sepsis have been observed by various other authors.[ 4, 18, 19, 20, 21 ]. In the present study, C. tropicalis (43.58%), was the predominant isolate, followed by C.albicans (17.94%), C. parapsilosis(17.09%), C. glabrata (8.54%) and C. krusei (5.12%) A study done by Geol S et al. 6 in Rohtak, have reported C. tropicalisas most common(43%) species isolated from neonates with candidemia, followed by C.albicans(41%)and C. krusei(9%).Our findings were similar to the study carried out by Gunjanet al. 22 who had reported the isolation of C. tropicalis (44%) as the most common cause of neonatal candidemia. A study done by Sardana V et al. 4 found C. glabrata as most common cause of candidemia in neonates (39%), followed byC. tropicalis (26.4%) and C. parapsilosis (14.5%) .A study from Hyderabad by Sirinivas Rao MS et al. 23 found C.tropicalisas most common cause of candidemia in neonates ( 36.53%), followed byC. albicans (26.92%) and C. glabrata (19.23%) . Similar observations of change in trend of candidemia in NICU were also made by many other authors. 17, 24, 25 The emergence of NAC species has posed a serious issue leading to increased resistance to antifungal drugs, which has become a great therapeutic concern. C. glabrata and C. krusei are innately resistant to azoles. The change in the pattern might be due to widespread use of prophylactic or empiric antifungal therapy. 1, 2, 4, 8 In the present study, among the risk factors associated with candidemia, prematurity and LBW were more common followed by prolonged antibiotic usage, steroid therapy and ventilator support .
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A study by Juyal D etal. 8 observed that prematurity(73.49%) and LBW(67.42%) were the common risk factors which is almost similar to our study. Narang A et al. 26 and Romeo et al. 27 found that prematurity was associated with 94% and 85% cases of neonatal candidiasis respectively.
In our setup, feed intolerance was the most common clinical presentation, followed by abdominal distension, lethargy and failure to gain weight. Shettigar CG et al. 13 in a study from Mangalore have also reported feed intolerance(77.78%), abdominal distension(64.81%) and lethargy(61.11%) as the common clinical symptoms. Sardana V et al. 4 found respiratory distress as prominent clinical symptom (74.55%) followed by lethargy(64.55%) and feed intolerance (60.91%).
LIMITATION OF THE STUDY
Due to unavailability of resources, antifungal susceptibility testing of the Candida isolates could not be done.
V. Conclusion
A mycological shift towards the isolation of non-albicans Candida species in neonatal candidal sepsis definitely indicates a changing trend and the emergence of antifungal drug resistance. Strict infection control strategies and a restrictive policy of antibiotic use should be implemented to reduce the morbidity and mortality associated with candidiasis.
Preventive measures such as use of filters for parenteral nutrition, prophylactic antifungal use, and a restrictive policy of antibiotic use to decrease Candida infection rates should be implemented
